| Bioactivity | BCR-ABL kinase-IN-3 (dihydrocholide) (example 1) is a potent inhibitor of BCR-ABL that plays an important role in acute myeloid leukemia (AML) research[1]. |
| Name | BCR-ABL kinase-IN-3 (dihydrocholide) |
| Formula | C35H32Cl2FN9O |
| Molar Mass | 684.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lee Doohyun, et al. Preparation of 3-((8-((1H-pyrazol-4-yl)amino)imidazo[1,2-a]pyridin-3-yl)ethynyl)-N-phenylbenzamide derivatives for prevention or treatment of cancer. World Intellectual Property Organization, WO2021172931 A1 2021-09-02 |
BCR-ABL kinase-IN-3 (dihydrocholide)
CAS: F: C35H32Cl2FN9O W: 684.59
BCR-ABL kinase-IN-3 (dihydrocholide) (example 1) is a potent inhibitor of BCR-ABL that plays an important role in acute
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.